BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Erdogan D, Kloek JJ, ten Kate FJW, Rauws EAJ, Busch ORC, Gouma DJ, van Gulik TM. Immunoglobulin G4-related sclerosing cholangitis in patients resected for presumed malignant bile duct strictures. British Journal of Surgery 2008;95:727-34. [DOI: 10.1002/bjs.6057] [Cited by in Crossref: 75] [Cited by in F6Publishing: 57] [Article Influence: 5.8] [Reference Citation Analysis]
Number Citing Articles
1 Fujita T, Kojima M, Gotohda N, Takahashi S, Nakagohri T, Konishi M, Ochiai A, Kinoshita T. Incidence, clinical presentation and pathological features of benign sclerosing cholangitis of unknown origin masquerading as biliary carcinoma. J Hepatobiliary Pancreat Sci. 2010;17:139-146. [PMID: 19399359 DOI: 10.1007/s00534-009-0115-5] [Cited by in Crossref: 21] [Cited by in F6Publishing: 13] [Article Influence: 1.8] [Reference Citation Analysis]
2 Walter D, Hartmann S, Herrmann E, Peveling-Oberhag J, Bechstein WO, Zeuzem S, Hansmann ML, Friedrich-Rust M, Albert JG. Eosinophilic cholangitis is a potentially underdiagnosed etiology in indeterminate biliary stricture. World J Gastroenterol. 2017;23:1044-1050. [PMID: 28246478 DOI: 10.3748/wjg.v23.i6.1044] [Cited by in CrossRef: 12] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
3 Lin J, Cummings OW, Greenson JK, House MG, Liu X, Nalbantoglu I, Pai R, Davidson DD, Reuss SA. IgG4-related sclerosing cholangitis in the absence of autoimmune pancreatitis mimicking extrahepatic cholangiocarcinoma. Scand J Gastroenterol. 2015;50:447-453. [PMID: 25635498 DOI: 10.3109/00365521.2014.962603] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
4 Wiggers JK, Groot Koerkamp B, van Klaveren D, Coelen RJ, Nio CY, Allen PJ, Besselink MG, Busch OR, D'Angelica MI, DeMatteo RP, Kingham TP, van Gulik TM, Jarnagin WR. Preoperative Risk Score to Predict Occult Metastatic or Locally Advanced Disease in Patients with Resectable Perihilar Cholangiocarcinoma on Imaging. J Am Coll Surg. 2018;227:238-246.e2. [PMID: 29627334 DOI: 10.1016/j.jamcollsurg.2018.03.041] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
5 Ruys AT, Bennink RJ, van Westreenen HL, Engelbrecht MR, Busch OR, Gouma DJ, van Gulik TM. FDG-positron emission tomography/computed tomography and standardized uptake value in the primary diagnosis and staging of hilar cholangiocarcinoma. HPB (Oxford. ). 2011;13:256-262. [PMID: 21418131 DOI: 10.1111/j.1477-2574.2010.00280.x] [Cited by in Crossref: 26] [Cited by in F6Publishing: 24] [Article Influence: 2.6] [Reference Citation Analysis]
6 Chapman MH, Thorburn D, Hirschfield GM, Webster GGJ, Rushbrook SM, Alexander G, Collier J, Dyson JK, Jones DE, Patanwala I, Thain C, Walmsley M, Pereira SP. British Society of Gastroenterology and UK-PSC guidelines for the diagnosis and management of primary sclerosing cholangitis. Gut. 2019;68:1356-1378. [PMID: 31154395 DOI: 10.1136/gutjnl-2018-317993] [Cited by in Crossref: 55] [Cited by in F6Publishing: 34] [Article Influence: 27.5] [Reference Citation Analysis]
7 Iwasaki S, Kamisawa T, Koizumi S, Chiba K, Tabata T, Kuruma S, Kishimoto Y, Igarashi Y. Assessment in steroid trial for IgG4-related sclerosing cholangitis. Adv Med Sci 2015;60:211-5. [PMID: 25863870 DOI: 10.1016/j.advms.2015.02.006] [Cited by in Crossref: 14] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
8 Miki A, Sakuma Y, Ohzawa H, Sanada Y, Sasanuma H, Lefor AT, Sata N, Yasuda Y. Immunoglobulin G4-related sclerosing cholangitis mimicking hilar cholangiocarcinoma diagnosed with following bile duct resection: report of a case. Int Surg 2015;100:480-5. [PMID: 25785331 DOI: 10.9738/INTSURG-D-14-00230.1] [Cited by in Crossref: 11] [Cited by in F6Publishing: 5] [Article Influence: 2.2] [Reference Citation Analysis]
9 Kalaitzakis E, Webster GJ. Endoscopic diagnosis of biliary tract disease: . Current Opinion in Gastroenterology 2012;28:273-9. [DOI: 10.1097/mog.0b013e328351436e] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
10 Wiggers JK, Groot Koerkamp B, Cieslak KP, Doussot A, van Klaveren D, Allen PJ, Besselink MG, Busch OR, D'Angelica MI, DeMatteo RP, Gouma DJ, Kingham TP, van Gulik TM, Jarnagin WR. Postoperative Mortality after Liver Resection for Perihilar Cholangiocarcinoma: Development of a Risk Score and Importance of Biliary Drainage of the Future Liver Remnant. J Am Coll Surg 2016; 223: 321-331. e1. [PMID: 27063572 DOI: 10.1016/j.jamcollsurg.2016.03.035] [Cited by in Crossref: 94] [Cited by in F6Publishing: 75] [Article Influence: 18.8] [Reference Citation Analysis]
11 Li J, Zhao C, Shen Y. Autoimmune cholangitis and cholangiocarcinoma: Autoimmune cholangitis and cholangiocarcinoma. J Gastroenterol Hepatol 2012;27:1783-9. [DOI: 10.1111/j.1440-1746.2012.07287.x] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
12 Bankov K, Döring C, Schneider M, Hartmann S, Winkelmann R, Albert JG, Bechstein WO, Zeuzem S, Hansmann ML, Peveling-Oberhag J, Walter D. Sequencing of intraductal biopsies is feasible and potentially impacts clinical management of patients with indeterminate biliary stricture and cholangiocarcinoma. Clin Transl Gastroenterol 2018;9:151. [PMID: 29712892 DOI: 10.1038/s41424-018-0015-6] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
13 Okada H, Uza N, Matsumori T, Matsumoto S, Muramoto Y, Ota S, Nakamura T, Yoshida H, Hirano T, Kuwada T, Marui S, Sogabe Y, Morita T, Kakiuchi N, Mima A, Ueda T, Nishikawa Y, Tsuda M, Maruno T, Shiokawa M, Takahashi K, Taura K, Minamiguchi S, Kodama Y, Seno H. A novel technique for mapping biopsy of bile duct cancer. Endoscopy 2021;53:647-51. [PMID: 32961577 DOI: 10.1055/a-1248-2138] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
14 Wakai T, Shirai Y, Sakata J, Maruyama T, Ohashi T, Korira PV, Ajioka Y, Hatakeyama K. Clinicopathological Features of Benign Biliary Strictures Masquerading as Biliary Malignancy. The American Surgeon 2012;78:1388-91. [DOI: 10.1177/000313481207801232] [Cited by in Crossref: 33] [Cited by in F6Publishing: 8] [Article Influence: 3.7] [Reference Citation Analysis]
15 Feng L, You Z, Ma D, Yan L, Cheng H, Gou J, Chen L. Immunoglobulin (Ig) G4-related sclerosing cholangitis in patients resected for presumed perihilar cholangiocarcinoma: a 10-year experience. Ann Transl Med 2021;9:415. [PMID: 33842636 DOI: 10.21037/atm-21-140] [Reference Citation Analysis]
16 Dawwas MF, Oppong KW, Webster GJ. Endoscopic assessment and management of biliary strictures. Frontline Gastroenterol. 2016;7:170-175. [PMID: 28839854 DOI: 10.1136/flgastro-2015-100570] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 1.2] [Reference Citation Analysis]
17 Maillette de Buy Wenniger LJ, Doorenspleet ME, Klarenbeek PL, Verheij J, Baas F, Elferink RP, Tak PP, de Vries N, Beuers U. Immunoglobulin G4+ clones identified by next-generation sequencing dominate the B cell receptor repertoire in immunoglobulin G4 associated cholangitis. Hepatology. 2013;57:2390-2398. [PMID: 23300096 DOI: 10.1002/hep.26232] [Cited by in Crossref: 90] [Cited by in F6Publishing: 70] [Article Influence: 11.3] [Reference Citation Analysis]
18 Tabata T, Kamisawa T, Hara S, Kuruma S, Chiba K, Kuwata G, Fujiwara T, Egashira H, Koizumi K, Fujiwara J, Arakawa T, Momma K, Kurata M, Honda G, Tsuruta K, Itoi T. Differentiating immunoglobulin g4-related sclerosing cholangitis from hilar cholangiocarcinoma. Gut Liver 2013;7:234-8. [PMID: 23560161 DOI: 10.5009/gnl.2013.7.2.234] [Cited by in Crossref: 23] [Cited by in F6Publishing: 11] [Article Influence: 2.9] [Reference Citation Analysis]
19 Requarth J. Image-Guided Palliative Care Procedures. Surgical Clinics of North America 2011;91:367-402. [DOI: 10.1016/j.suc.2010.12.009] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 1.1] [Reference Citation Analysis]
20 Ratti F, Cipriani F, Ferla F, Catena M, Paganelli M, Aldrighetti LAM. Hilar Cholangiocarcinoma: Preoperative Liver Optimization with Multidisciplinary Approach. Toward a Better Outcome. World J Surg 2013;37:1388-96. [DOI: 10.1007/s00268-013-1980-2] [Cited by in Crossref: 30] [Cited by in F6Publishing: 26] [Article Influence: 3.8] [Reference Citation Analysis]
21 Kubo N, Suzuki H, Kobayashi T, Araki K, Sasaki S, Wada W, Kuwano H. Usefulness of steroid administration for diagnosis of IgG4-related sclerosing cholangitis. Int Surg 2012;97:145-9. [PMID: 23343338 DOI: 10.9738/CC78.1] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
22 Agrawal S, Daruwala C, Khurana J. Distinguishing autoimmune pancreatitis from pancreaticobiliary cancers: current strategy. Ann Surg. 2012;255:248-258. [PMID: 21997803 DOI: 10.1097/SLA.0b013e3182324549] [Cited by in Crossref: 21] [Cited by in F6Publishing: 3] [Article Influence: 2.3] [Reference Citation Analysis]
23 Maeda E, Akahane M, Yoshioka N, Takao H, Matsuda I, Kamiya K, Hirano K, Tada M, Ohtsu H, Fukushima N, Ohtomo K. Comparison of CT findings of biliary tract changes with autoimmune pancreatitis and extrahepatic bile duct cholangiocarcinoma. Jpn J Radiol 2012;30:227-34. [PMID: 22200917 DOI: 10.1007/s11604-011-0035-6] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
24 Rungsakulkij N, Sornmayura P, Tannaphai P. Isolated IgG4-related sclerosing cholangitis misdiagnosed as malignancy in an area with endemic cholangiocarcinoma: a case report. BMC Surg. 2017;17:17. [PMID: 28202062 DOI: 10.1186/s12893-017-0214-1] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
25 Otsuka S, Ebata T, Yokoyama Y, Igami T, Mizuno T, Yamaguchi J, Onoe S, Watanabe N, Shimoyama Y, Nagino M. Benign hilar bile duct strictures resected as perihilar cholangiocarcinoma. Br J Surg. 2019;106:1504-1511. [PMID: 31386198 DOI: 10.1002/bjs.11257] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
26 Montano-Loza AJ, Lalor E, Mason AL. Recognizing immunoglobulin G4 related overlap syndromes in patients with pancreatic and hepatobiliary diseases. Can J Gastroenterol 2008;22:840-6. [PMID: 18925309 DOI: 10.1155/2008/586173] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
27 Fujita T, Kojima M, Kato Y, Gotohda N, Takahashi S, Konishi M, Kinoshita T. Clinical and histopathological study of "follicular cholangitis": Sclerosing cholangitis with prominent lymphocytic infiltration masquerading as hilar cholangiocarcinoma. Hepatol Res 2010;40:1239-47. [PMID: 20880060 DOI: 10.1111/j.1872-034X.2010.00716.x] [Cited by in Crossref: 20] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
28 Oseini AM, Chaiteerakij R, Shire AM, Ghazale A, Kaiya J, Moser CD, Aderca I, Mettler TA, Therneau TM, Zhang L, Takahashi N, Chari ST, Roberts LR. Utility of serum immunoglobulin G4 in distinguishing immunoglobulin G4-associated cholangitis from cholangiocarcinoma. Hepatology. 2011;54:940-948. [PMID: 21674559 DOI: 10.1002/hep.24487] [Cited by in Crossref: 126] [Cited by in F6Publishing: 95] [Article Influence: 12.6] [Reference Citation Analysis]
29 Kalaitzakis E, Webster GJ, Oppong KW, Kallis Y, Vlavianos P, Huggett M, Dawwas MF, Lekharaju V, Hatfield A, Westaby D, Sturgess R. Diagnostic and therapeutic utility of single-operator peroral cholangioscopy for indeterminate biliary lesions and bile duct stones. Eur J Gastroenterol Hepatol. 2012;24:656-664. [PMID: 22433791 DOI: 10.1097/meg.0b013e3283526fa1] [Cited by in Crossref: 76] [Cited by in F6Publishing: 33] [Article Influence: 8.4] [Reference Citation Analysis]
30 Fukuda S, Mukai S, Shimizu S, Kouchi M, Fujisaki S, Takahashi M, Sakimoto H, Eto T, Takahashi M, Nishida T. Heterotopic gastric mucosa in the hilar bile duct mimicking hilar cholangiocarcinoma: report of a case. Surg Today 2013;43:91-5. [PMID: 22706785 DOI: 10.1007/s00595-012-0221-x] [Cited by in Crossref: 12] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
31 Smit WL, Culver EL, Chapman RW. New Thoughts on Immunoglobulin G4–Related Sclerosing Cholangitis. Clinics in Liver Disease 2016;20:47-65. [DOI: 10.1016/j.cld.2015.08.004] [Cited by in Crossref: 9] [Cited by in F6Publishing: 4] [Article Influence: 1.8] [Reference Citation Analysis]
32 Roos E, Hubers LM, Coelen RJS, Doorenspleet ME, de Vries N, Verheij J, Beuers U, van Gulik TM. IgG4-Associated Cholangitis in Patients Resected for Presumed Perihilar Cholangiocarcinoma: a 30-Year Tertiary care Experience: . American Journal of Gastroenterology 2018;113:765-72. [DOI: 10.1038/s41395-018-0036-5] [Cited by in Crossref: 17] [Cited by in F6Publishing: 12] [Article Influence: 5.7] [Reference Citation Analysis]
33 Kloek JJ, van Delden OM, Erdogan D, ten Kate FJ, Rauws EA, Busch OR, Gouma DJ, van Gulik TM. Differentiation of malignant and benign proximal bile duct strictures: the diagnostic dilemma. World J Gastroenterol. 2008;14:5032-5038. [PMID: 18763286 DOI: 10.3748/wjg.14.5032] [Cited by in CrossRef: 23] [Cited by in F6Publishing: 21] [Article Influence: 1.8] [Reference Citation Analysis]
34 Kalaitzakis E, Levy M, Kamisawa T, Johnson GJ, Baron TH, Topazian MD, Takahashi N, Kanno A, Okazaki K, Egawa N, Uchida K, Sheikh K, Amin Z, Shimosegawa T, Sandanayake NS, Church NI, Chapman MH, Pereira SP, Chari S, Webster GJ. Endoscopic retrograde cholangiography does not reliably distinguish IgG4-associated cholangitis from primary sclerosing cholangitis or cholangiocarcinoma. Clin Gastroenterol Hepatol. 2011;9:800-803.e2. [PMID: 21699807 DOI: 10.1016/j.cgh.2011.05.019] [Cited by in Crossref: 58] [Cited by in F6Publishing: 44] [Article Influence: 5.8] [Reference Citation Analysis]
35 Saavedra-perez D, Vaquero EC, Ayuso JR, Fernandez-cruz L. Pancreatitis autoinmune: un dilema quirúrgico. Cirugía Española 2014;92:645-53. [DOI: 10.1016/j.ciresp.2014.01.013] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
36 Itoh S, Nagasaka T, Suzuki K, Satake H, Ota T, Naganawa S. Lymphoplasmacytic sclerosing cholangitis: assessment of clinical, CT, and pathological findings. Clin Radiol 2009;64:1104-14. [PMID: 19822244 DOI: 10.1016/j.crad.2009.07.006] [Cited by in Crossref: 27] [Cited by in F6Publishing: 19] [Article Influence: 2.3] [Reference Citation Analysis]
37 Yata M, Suzuki K, Furuhashi N, Kawakami K, Kawai Y, Naganawa S. Comparison of the multidetector-row computed tomography findings of IgG4-related sclerosing cholangitis and extrahepatic cholangiocarcinoma. Clin Radiol 2016;71:203-10. [PMID: 26703117 DOI: 10.1016/j.crad.2015.10.024] [Cited by in Crossref: 17] [Cited by in F6Publishing: 12] [Article Influence: 2.8] [Reference Citation Analysis]
38 Navaneethan U, Gutierrez NG, Jegadeesan R, Venkatesh PG, Poptic E, Sanaka MR, Vargo JJ, Parsi MA. IgG4 Levels in Bile for Distinguishing IgG4-Associated Cholangiopathy from Other Biliary Disorders: A Single Blinded Pilot Study. Clin Endosc. 2014;47:555-559. [PMID: 25505722 DOI: 10.5946/ce.2014.47.6.555] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
39 de Vries E, Tielbeke F, Hubers L, Helder J, Mostafavi N, Verheij J, van Hooft J, Besselink M, Fockens P, de Vries N, Beuers U. IgG4/IgG RNA ratio does not accurately discriminate IgG4-related disease from pancreatobiliary cancer. JHEP Rep 2020;2:100116. [PMID: 32642635 DOI: 10.1016/j.jhepr.2020.100116] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
40 Matull WR, Dhar DK, Ayaru L, Sandanayake NS, Chapman MH, Dias A, Bridgewater J, Webster GJ, Bong JJ, Davidson BR, Pereira SP. R0 but not R1/R2 resection is associated with better survival than palliative photodynamic therapy in biliary tract cancer. Liver Int 2011;31:99-107. [PMID: 20846273 DOI: 10.1111/j.1478-3231.2010.02345.x] [Cited by in Crossref: 30] [Cited by in F6Publishing: 24] [Article Influence: 2.7] [Reference Citation Analysis]
41 van Heerde MJ, Biermann K, Zondervan PE, Kazemier G, van Eijck CH, Pek C, Kuipers EJ, van Buuren HR. Prevalence of autoimmune pancreatitis and other benign disorders in pancreatoduodenectomy for presumed malignancy of the pancreatic head. Dig Dis Sci. 2012;57:2458-2465. [PMID: 22588243 DOI: 10.1007/s10620-012-2191-7] [Cited by in Crossref: 46] [Cited by in F6Publishing: 38] [Article Influence: 5.1] [Reference Citation Analysis]
42 Kalaitzakis E, Sturgess R, Kaltsidis H, Oppong K, Lekharaju V, Bergenzaun P, Vlavianos P, Sharma H, Westaby D, Webster GJ. Diagnostic utility of single-user peroral cholangioscopy in sclerosing cholangitis. Scandinavian Journal of Gastroenterology 2014;49:1237-44. [DOI: 10.3109/00365521.2014.936032] [Cited by in Crossref: 29] [Cited by in F6Publishing: 19] [Article Influence: 4.1] [Reference Citation Analysis]
43 Oh HC, Kim MH, Lee KT, Lee JK, Moon SH, Song TJ, Eum J, Park do H, Lee SS, Seo DW. Clinical clues to suspicion of IgG4-associated sclerosing cholangitis disguised as primary sclerosing cholangitis or hilar cholangiocarcinoma. J Gastroenterol Hepatol. 2010;25:1831-1837. [PMID: 21091993 DOI: 10.1111/j.1440-1746.2010.06411.x] [Cited by in Crossref: 41] [Cited by in F6Publishing: 25] [Article Influence: 4.1] [Reference Citation Analysis]
44 Culver EL, Chapman RW. IgG4-related hepatobiliary disease: an overview. Nat Rev Gastroenterol Hepatol 2016;13:601-12. [DOI: 10.1038/nrgastro.2016.132] [Cited by in Crossref: 44] [Cited by in F6Publishing: 32] [Article Influence: 8.8] [Reference Citation Analysis]
45 Shimada H, Endo I, Shimada K, Matsuyama R, Kobayashi N, Kubota K. The current diagnosis and treatment of benign biliary stricture. Surg Today 2012;42:1143-53. [DOI: 10.1007/s00595-012-0333-3] [Cited by in Crossref: 27] [Cited by in F6Publishing: 13] [Article Influence: 3.0] [Reference Citation Analysis]
46 Ruys AT, van Haelst S, Busch OR, Rauws EA, Gouma DJ, van Gulik TM. Long-term survival in hilar cholangiocarcinoma also possible in unresectable patients. World J Surg. 2012;36:2179-2186. [PMID: 22569746 DOI: 10.1007/s00268-012-1638-5] [Cited by in Crossref: 36] [Cited by in F6Publishing: 34] [Article Influence: 4.0] [Reference Citation Analysis]
47 Bahra M. [Surgical treatment of distal cholangiocarcinoma]. Chirurg 2021;92:788-95. [PMID: 34232340 DOI: 10.1007/s00104-021-01453-2] [Reference Citation Analysis]
48 Goodchild G, Pereira SP, Webster G. Immunoglobulin G4-related sclerosing cholangitis. Korean J Intern Med. 2018;33:841-850. [PMID: 30045615 DOI: 10.3904/kjim.2018.018] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
49 Lee YS, Lee SH, Lee MG, Lee SJ, Hwang JH, Shin E, Lee YJ. Immunoglobulin g4-related disease mimicking unresectable gallbladder cancer. Gut Liver 2013;7:616-20. [PMID: 24073322 DOI: 10.5009/gnl.2013.7.5.616] [Cited by in Crossref: 20] [Cited by in F6Publishing: 9] [Article Influence: 2.5] [Reference Citation Analysis]
50 Lian MJ, Liu S, Wu GY, Liu SY. Serum IgG4 and IgG for the diagnosis of autoimmune pancreatitis: A systematic review with meta-analysis. Clin Res Hepatol Gastroenterol 2016;40:99-109. [PMID: 26160477 DOI: 10.1016/j.clinre.2015.06.002] [Cited by in Crossref: 12] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
51 Hubers LM, Maillette de Buy Wenniger LJ, Doorenspleet ME, Klarenbeek PL, Verheij J, Rauws EA, van Gulik TM, Oude Elferink RPJ, van de Graaf SFJ, de Vries N, Beuers U. IgG4-Associated Cholangitis: A Comprehensive Review. Clinic Rev Allerg Immunol 2015;48:198-206. [DOI: 10.1007/s12016-014-8430-2] [Cited by in Crossref: 38] [Cited by in F6Publishing: 28] [Article Influence: 5.4] [Reference Citation Analysis]
52 Lytras D, Kalaitzakis E, Webster GJ, Imber CJ, Amin Z, Rodriguez-Justo M, Pereira SP, Olde Damink SW, Malagoʼ M. Cholangiocarcinoma or IgG4-associated cholangitis: how feasible it is to avoid unnecessary surgical interventions? Ann Surg 2012;256:1059-67. [PMID: 22580936 DOI: 10.1097/SLA.0b013e3182533a0a] [Cited by in Crossref: 22] [Cited by in F6Publishing: 10] [Article Influence: 2.8] [Reference Citation Analysis]
53 van Gulik TM, Kloek JJ, Ruys AT, Busch OR, van Tienhoven GJ, Lameris JS, Rauws EA, Gouma DJ. Multidisciplinary management of hilar cholangiocarcinoma (Klatskin tumor): extended resection is associated with improved survival. Eur J Surg Oncol. 2011;37:65-71. [PMID: 21115233 DOI: 10.1016/j.ejso.2010.11.008] [Cited by in Crossref: 61] [Cited by in F6Publishing: 61] [Article Influence: 5.5] [Reference Citation Analysis]
54 Matsubayashi H, Uesaka K, Sugiura T, Ohgi K, Sasaki K, Ono H. IgG4-related sclerosing cholangitis without obvious pancreatic lesion: difficulty in differential diagnosis. J Dig Dis 2014;15:394-403. [PMID: 24690458 DOI: 10.1111/1751-2980.12149] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
55 Sugimoto S, Matsubayashi H, Kimura H, Sasaki K, Nagata K, Ohno S, Uesaka K, Mori K, Imai K, Hotta K. Diagnosis of bile duct cancer by bile cytology: usefulness of post-brushing biliary lavage fluid. Endosc Int Open. 2015;3:E323-E328. [PMID: 26357678 DOI: 10.1055/s-0034-1391666] [Cited by in Crossref: 19] [Cited by in F6Publishing: 14] [Article Influence: 3.2] [Reference Citation Analysis]
56 Hegade VS, Sheridan MB, Huggett MT. Diagnosis and management of IgG4-related disease. Frontline Gastroenterol. 2019;10:275-283. [PMID: 31288262 DOI: 10.1136/flgastro-2018-101001] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 2.3] [Reference Citation Analysis]
57 Hubers LM, Maillette de Buy Wenniger LJ, Doorenspleet ME, Klarenbeek PL, Verheij J, Rauws EA, van Gulik TM, Oude Elferink RP, van de Graaf SF, de Vries N. IgG4-associated cholangitis: a comprehensive review. Clin Rev Allergy Immunol. 2015;48:198-206. [PMID: 24958363 DOI: 10.1007/ s12016-014-8430-2] [Reference Citation Analysis]